Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

03 oct. 2018 17h15 HE | Source: Celsion CORP

Celsion Corporation Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

LAWRENCEVILLE, N.J., Oct. 03, 2018 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that on September 28, 2018, the Compensation...
17 sept. 2018 08h30 HE | Source: Celsion CORP

Celsion Appoints Marianne Lambertson as Vice President of Communications and Investor Relations

Lambertson brings executive experience to the newly created position, reinforcing Celsion’s commitment to its strategic communications and investor relations objectives ...
06 sept. 2018 08h00 HE | Source: Celsion CORP

Celsion Announces First Patient Randomized in the Gene-Mediated Immunotherapy (GEN-1) Study of Newly Diagnosed Stage III/IV Ovarian Cancer Patients

OVATION II Study Will Evaluate Initial and Maintenance Dosing of GEN-1 on Progression-Free Survival in a Two-Arm, Randomized Trial of Up to 130 Patients LAWRENCEVILLE, N.J., Sept. 06, 2018 (GLOBE...